Washington: Scientists have found that a drug commonly used to treat chronic obstructive pulmonary disease (COPD) could also be used for the treatment of adults whose asthma is not well-controlled on low doses of inhaled corticosteroids.Researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, conducted the study."This study`s results show that tiotropium bromide might provide an alternative to other asthma treatments, expanding options available to patients for controlling their asthma," said Susan B. Shurin of National Heart, Lung, and Blood Institute (NHLBI).
Tiotropium bromide was shown to be effective using several asthma control measurements, including patients` day-to-day lung function as well as the number of days in which they had no asthma symptoms and did not need to use their albuterol rescue inhalers.When patients began the trial, their average number of such "asthma control days" was 77 per year (extrapolated from the treatment period).Doubling corticosteroids gave patients another 19 symptom-free days on average, while adding tiotropium to low-dose corticosteroids gave them another 48.The findings were published in the New England Journal of Medicine and presented at the Annual Congress of the European Respiratory Society in Barcelona. (ANI)
Curfew relaxed for 4 hours in Saharanpur
Refund fares for flight delay: DGCA to Spicejet
1 child killed every hour in Gaza: UN
Delhi shame: Class 10th student gang-raped in Uttam Nagar at gun point